Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 3:26 pm Unchanged | 2024-10-31 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,682,275 13.500% | 0 (Unchanged) | Filing History |
| 2024-10-25 2:19 pm Purchase | 2024-10-21 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,682,275 13.500% | 2,501,876 (+1386.86%) | Filing History |
| 2024-09-30 5:18 pm Purchase | 2024-09-26 | 13D | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | 8,829,053 49.900% | 7,128,203 (+419.10%) | Filing History |
| 2024-04-29 4:08 pm Purchase | 2024-04-22 | 13D | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,700,850 19.990% | 1,438,007 (+547.10%) | Filing History |
| 2024-04-29 4:05 pm Purchase | 2024-04-17 | 13G | Benitec Biopharma Inc. BNTC | HBM Healthcare Investments (Cayman) Ltd. | 849,893 9.990% | 849,893 (New Position) | Filing History |
| 2024-04-29 11:44 am Purchase | 2024-04-22 | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 791,235 8.890% | 693,032 (+705.71%) | Filing History |
| 2024-04-11 12:10 pm Purchase | 2023-08-11 | 13G | Benitec Biopharma Inc. BNTC | ADAGE CAPITAL PARTNERS GP L.L.C. | 264,510 9.990% | 75,322 (+39.81%) | Filing History |
| 2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | Citadel Advisors LLC | 95,356 3.600% | -84,674 (-47.03%) | Filing History |
| 2024-02-14 10:00 am Sale | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 180,399 7.000% | -25,771 (-12.50%) | Filing History |
| 2024-02-13 5:16 pm Purchase | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | 262,843 9.990% | 262,843 (New Position) | Filing History |
| 2023-12-11 12:41 pm Purchase | 2023-11-30 | 13G | Benitec Biopharma Inc. BNTC | FRANKLIN RESOURCES INC BEN | 588,237 22.900% | 2 (+0.00%) | Filing History |
| 2023-09-11 11:27 am Purchase | 2023-08-31 | 13G | Benitec Biopharma Inc. BNTC | FRANKLIN RESOURCES INC BEN | 588,235 28.500% | 588,235 (New Position) | Filing History |
| 2023-08-25 4:30 pm Purchase | 2023-08-15 | 13G | Benitec Biopharma Inc. BNTC | ADAGE CAPITAL PARTNERS GP L.L.C. | 189,188 7.500% | 189,188 (New Position) | Filing History |
| 2023-08-21 4:07 pm Purchase | 2023-08-11 | 13G | Benitec Biopharma Inc. BNTC | Citadel Advisors LLC | 180,030 6.900% | 180,030 (New Position) | Filing History |
| 2023-08-18 3:55 pm Purchase | 2023-08-09 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 206,170 9.900% | 206,170 (New Position) | Filing History |
| 2023-08-18 10:50 am Sale | 2023-08-08 | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 98,203 3.890% | -24,395 (-19.90%) | Filing History |
| 2023-04-18 4:16 pm Sale | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | 177,660 9.990% | -194,617 (-52.28%) | Filing History |
| 2023-02-14 11:24 am Sale | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | CVI Investments, Inc. | 86,447 4.900% | -1,789 (-2.03%) | Filing History |
| 2023-02-13 12:25 pm Purchase | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | 372,276 9.990% | 327,041 (+722.98%) | Filing History |
| 2023-02-07 5:38 pm Sale | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | SilverArc Capital Management, LLC | 0 0.000% | -34,559 (Position Closed) | Filing History |